PDF herunterladen
CC BY-NC-ND 4.0 · Thromb Haemost 2019; 119(10): 1624-1631
DOI: 10.1055/s-0039-1693701
Coagulation and Fibrinolysis
Georg Thieme Verlag KG Stuttgart · New York

Decoration of Fibrin with Extracellular Chaperones

Simone Talens
1   Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands
,
Frank W. G. Leebeek
1   Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands
,
Robert Veerhuis
2   Clinical Chemistry Department, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands
3   Psychiatry Department, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands
,
Dingeman C. Rijken
1   Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

26. März 2019

12. Juni 2019

Publikationsdatum:
22. August 2019 (online)

    Lizenzen und Reprints

Erratum zu diesem Artikel:

ErratumThromb Haemost 2019; 119(10): e1-e1
DOI: 10.1055/s-0040-1702204

Abstract

Background Many proteins bind to fibrin during clot formation in plasma. We previously identified by mass spectrometry the most abundant proteins that noncovalently bind to fibrin clots. Several of these proteins (e.g., apolipoprotein J/clusterin, haptoglobin, α2-macroglobulin, α1-antitrypsin) can act as extracellular chaperones.

Objective We hypothesize that clot-binding proteins may interact with fibrin as chaperones. The goal of this study is to test this hypothesis and to investigate the origin of the cross-β or amyloid structures in fibrin clots, which are associated with protein unfolding.

Methods and Results A thioflavin T assay was used to detect cross-β structures. A steadily increasing amount was measured in the fibrinogen fraction of plasma during heat stress, a standard treatment to induce unfolding of proteins. Heat-stressed plasma was clotted and clot-bound proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The results showed that the amounts of the clot-bound proteins were related to the duration of the heat stress. This indicates that cross-β structures in unfolded fibrin(ogen) are involved in clot binding of the proteins, which supports our chaperone hypothesis. A contributing role of fibrin formation itself was studied by clotting purified fibrinogen with thrombin in the presence of thioflavin T. The fluorescence intensity increased in time in the presence of thrombin, but did not increase in its absence. This provides evidence for the generation of cross-β structures during fibrin formation.

Conclusion Fibrin clots generated in plasma are decorated with extracellular chaperones. The binding of these chaperones involves cross-β structures originating both from unfolded fibrinogen and from fibrin formation.

Keywords

amyloid structure - blood coagulation - extracellular chaperones - fibrin - fibrinogen

Authors' Contributions

S.T. designed the research, performed the laboratory experiments, analyzed and interpreted data, and wrote the manuscript; F.W.G.L. designed the research and interpreted data; R.V. provided critical support about amyloid structures and for the experiments with thioflavin T; D.C.R. designed the research, analyzed and interpreted data, and wrote the manuscript. All authors critically reviewed the manuscript and gave their consent.


 

  • References

  • 1 Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005; 70: 247-299
    PubMedGoogle Scholar
  • 2 Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona É. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011; 91 (03) 931-972
    CrossrefPubMedGoogle Scholar
  • 3 Rijken DC, Uitte de Willige S. Inhibition of fibrinolysis by coagulation factor XIII. BioMed Res Int 2017; 2017: 1209676
    PubMedGoogle Scholar
  • 4 Nikolajsen CL, Dyrlund TF, Poulsen ET, Enghild JJ, Scavenius C. Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot. J Biol Chem 2014; 289 (10) 6526-6534
    CrossrefPubMedGoogle Scholar
  • 5 Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem 2017; 82: 405-456
    PubMedGoogle Scholar
  • 6 Liu CY, Nossel HL, Kaplan KL. The binding of thrombin by fibrin. J Biol Chem 1979; 254 (20) 10421-10425
    CrossrefPubMedGoogle Scholar
  • 7 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257 (06) 2912-2919
    CrossrefPubMedGoogle Scholar
  • 8 Talens S, Leebeek FW, Demmers JA, Rijken DC. Identification of fibrin clot-bound plasma proteins. PLoS One 2012; 7 (08) e41966
    CrossrefPubMedGoogle Scholar
  • 9 Howes JM, Richardson VR, Smith KA. , et al. Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diab Vasc Dis Res 2012; 9 (03) 216-225
    CrossrefPubMedGoogle Scholar
  • 10 Suski M, Siudut J, Ząbczyk M, Korbut R, Olszanecki R, Undas A. Shotgun analysis of plasma fibrin clot-bound proteins in patients with acute myocardial infarction. Thromb Res 2015; 135 (04) 754-759
    CrossrefPubMedGoogle Scholar
  • 11 Stachowicz A, Siudut J, Suski M. , et al. Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism. Clin Proteomics 2017; 14: 38
    CrossrefPubMedGoogle Scholar
  • 12 Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR. Extracellular chaperones and proteostasis. Annu Rev Biochem 2013; 82: 295-322
    CrossrefPubMedGoogle Scholar
  • 13 Gralnick HR, Givelber HM, Shainoff JR, Finlayson JS. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Invest 1971; 50 (09) 1819-1830
    CrossrefPubMedGoogle Scholar
  • 14 Talens S, Malfliet JJ, van Hal PT, Leebeek FW, Rijken DC. Identification and characterization of α1-antitrypsin in fibrin clots. J Thromb Haemost 2013; 11 (07) 1319-1328
    CrossrefPubMedGoogle Scholar
  • 15 Carter AM, Cymbalista CM, Spector TD, Grant PJ. ; EuroCLOT Investigators. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol 2007; 27 (12) 2783-2789
    CrossrefPubMedGoogle Scholar
  • 16 Vassar PS, Culling CF. Fluorescent stains, with special reference to amyloid and connective tissues. Arch Pathol 1959; 68: 487-498
    PubMedGoogle Scholar
  • 17 Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 2010; 1804 (07) 1405-1412
    CrossrefPubMedGoogle Scholar
  • 18 Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011; 475 (7356): 324-332
    CrossrefPubMedGoogle Scholar
  • 19 Radcliffe R, Heinze T. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator?. Arch Biochem Biophys 1981; 211 (02) 750-761
    CrossrefPubMedGoogle Scholar
  • 20 Machovich R, Owen WG. Denatured proteins as cofactors for plasminogen activation. Arch Biochem Biophys 1997; 344 (02) 343-349
    CrossrefPubMedGoogle Scholar
  • 21 Kranenburg O, Bouma B, Kroon-Batenburg LM. , et al. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr Biol 2002; 12 (21) 1833-1839
    CrossrefPubMedGoogle Scholar
  • 22 Beringer DX, Fischer MJ, Meeldijk JD, van Donselaar EG, de Mol NJ, Kroon-Batenburg LM. Tissue-type plasminogen activator binds to Aβ and AIAPP amyloid fibrils with multiple domains. Amyloid 2013; 20 (02) 113-121
    CrossrefPubMedGoogle Scholar
  • 23 Constantinescu P, Brown RA, Wyatt AR, Ranson M, Wilson MR. Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones. J Biol Chem 2017; 292 (35) 14425-14437
    CrossrefPubMedGoogle Scholar
  • 24 Tang H, Fu Y, Zhan S, Luo Y. Alpha(E)C, the C-terminal extension of fibrinogen, has chaperone-like activity. Biochemistry 2009; 48 (18) 3967-3976
    CrossrefPubMedGoogle Scholar
  • 25 Wyatt AR, Wilson MR. Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. J Biol Chem 2010; 285 (06) 3532-3539
    CrossrefPubMedGoogle Scholar
  • 26 Wyatt AR, Kumita JR, Mifsud RW, Gooden CA, Wilson MR, Dobson CM. Hypochlorite-induced structural modifications enhance the chaperone activity of human α2-macroglobulin. Proc Natl Acad Sci U S A 2014; 111 (20) E2081-E2090
    CrossrefPubMedGoogle Scholar
  • 27 Shacter E, Williams JA, Lim M, Levine RL. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 1994; 17 (05) 429-437
    CrossrefPubMedGoogle Scholar
  • 28 Gebbink MF. Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis. J Thromb Haemost 2011; 9 (Suppl. 01) 174-181
    CrossrefPubMedGoogle Scholar
  • 29 Longstaff C, Thelwell C, Williams SC, Silva MM, Szabó L, Kolev K. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies. Blood 2011; 117 (02) 661-668
    CrossrefPubMedGoogle Scholar
  • 30 Sakharov DV, Plow EF, Rijken DC. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 1997; 272 (22) 14477-14482
    CrossrefPubMedGoogle Scholar
  • 31 Kell DB, Pretorius E. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. Prog Biophys Mol Biol 2017; 123: 16-41
    CrossrefPubMedGoogle Scholar
  • 32 Kell DB, Pretorius E. To what extent are the terminal stages of sepsis, septic shock, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome actually driven by a prion/amyloid form of fibrin?. Semin Thromb Hemost 2018; 44 (03) 224-238
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 33 Hudry-Clergeon G, Freyssinet JM, Torbet J, Marx J. Orientation of fibrin in strong magnetic fields. Ann N Y Acad Sci 1983; 408: 380-387
    CrossrefPubMedGoogle Scholar
  • 34 Tsurupa G, Pechik I, Litvinov RI. , et al. On the mechanism of αC polymer formation in fibrin. Biochemistry 2012; 51 (12) 2526-2538
    CrossrefPubMedGoogle Scholar
  • 35 Litvinov RI, Faizullin DA, Zuev YF, Weisel JW. The α-helix to β-sheet transition in stretched and compressed hydrated fibrin clots. Biophys J 2012; 103 (05) 1020-1027
    CrossrefPubMedGoogle Scholar
  • 36 Bhattacharyya J, Das KP. Molecular chaperone-like properties of an unfolded protein, alpha(s)-casein. J Biol Chem 1999; 274 (22) 15505-15509
    CrossrefPubMedGoogle Scholar
  • 37 Carrotta R, Canale C, Diaspro A, Trapani A, Biagio PL, Bulone D. Inhibiting effect of α(s1)-casein on Aβ(1-40) fibrillogenesis. Biochim Biophys Acta 2012; 1820 (02) 124-132
    CrossrefPubMedGoogle Scholar
  • 38 Morgan PE, Treweek TM, Lindner RA, Price WE, Carver JA. Casein proteins as molecular chaperones. J Agric Food Chem 2005; 53 (07) 2670-2683
    CrossrefPubMedGoogle Scholar
  • 39 Chung DW, Chen J, Ling M. , et al. High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion. Blood 2016; 127 (05) 637-645
    CrossrefPubMedGoogle Scholar